Our results showing that triphala exerts its biological efficacy in human colon cancer cells independent of their p53 status are extremely important outcomes for future translational potential in preventive intervention of colon cancer in the clinic; however, preclinical studies in mouse models of colon cancer are required to establish in vivo efficacy. This evidence concerns the gene TP53 and malignant colon neoplasm.